SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will serve on the International Finance Panel at BioContact 2007 on October 3, 2007 in Quebec City
News | 10. 03. 2007
